Clinical Trial Update: A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing PRC-063 with lisdexamfetamine to assess driving performance in adults with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Lisdexamfetamine (lisdexamfetamine dimesylate)
• PRC-063 (PRC-063)

Snippet

Sponsor: Rhodes Pharmaceuticals, L.P. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED